« Previous Next » Journal of Oral and Maxillofacial Surgery
Volume 65, Issue 3 , Pages 415-423 , March 2007

Nature and Frequency of Bisphosphonate-Associated Osteonecrosis of the Jaws in Australia

Tony Mavrokokki, BDS
- Staff Dentist, Oral and Maxillofacial Surgery Unit, Adelaide Dental Hospital and University of Adelaide, Adelaide, South Australia.
- Professor Goss has acted as a consultant to Novartis (International and Australia) and to Merck (International and Australia). Dr A. Mavrokokki has acted as a consultant to Novartis (Australia) and Dr A. Cheng to Merck (Australia).
Andrew Cheng, BDS
- Registrar, Oral and Maxillofacial Surgery Unit, Royal Adelaide Hospital, Adelaide Dental Hospital and University of Adelaide, Adelaide, South Australia.
- Professor Goss has acted as a consultant to Novartis (International and Australia) and to Merck (International and Australia). Dr A. Mavrokokki has acted as a consultant to Novartis (Australia) and Dr A. Cheng to Merck (Australia).
Brien Stein, MBBS, FRACP
- Medical Oncologist, Ashford Cancer Center, Ashford, and University of Adelaide, Adelaide, South Australia.
Alastair Goss, DDSC, FRACDS(OMS), FICD
- Professor and Director, Oral and Maxillofacial Surgery Unit, Royal Adelaide Hospital, Adelaide Dental Hospital, Adelaide, and Professor of Oral and Maxillofacial Surgery, School of Dentistry, University of Adelaide, Adelaide, South Australia.
- Professor Goss has acted as a consultant to Novartis (International and Australia) and to Merck (International and Australia). Dr A. Mavrokokki has acted as a consultant to Novartis (Australia) and Dr A. Cheng to Merck (Australia).
- Address correspondence and reprint requests to Dr Goss: Oral and Maxillofacial Surgery Unit, The University of Adelaide, Adelaide, Australia, 5005